Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suchanan Tanyapattrapong

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|April 14, 2026
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell LinesPritsana Raungrut, Suchanan Tanyapattrapong, Saowanee Maungchanburi, et al.
Current Issues in Molecular Biology|December 27, 2024
Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals <i>CSF3</i> as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet RegimensPritsana Raungrut, Suchanan Tanyapattrapong, Thipphanet Masjon, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 29, 2023
Predictive and Prognostic Value of TUBB3, RRM1, APE1, and Survivin Expression in Chemotherapy-Receiving Patients with Advanced Non‑Small Cell Lung CancerPritsana Raungrut, Suchanan Tanyapattrapong, Jirapon Jirapongsak, et al.
International Journal of Molecular Sciences|February 13, 2025
Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome AnalysesPritsana Raungrut, Jirapon Jirapongsak, Suchanan Tanyapattrapong, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|April 14, 2026
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell LinesPritsana Raungrut, Suchanan Tanyapattrapong, Saowanee Maungchanburi, et al.
Current Issues in Molecular Biology|December 27, 2024
Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals <i>CSF3</i> as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet RegimensPritsana Raungrut, Suchanan Tanyapattrapong, Thipphanet Masjon, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 29, 2023
Predictive and Prognostic Value of TUBB3, RRM1, APE1, and Survivin Expression in Chemotherapy-Receiving Patients with Advanced Non‑Small Cell Lung CancerPritsana Raungrut, Suchanan Tanyapattrapong, Jirapon Jirapongsak, et al.
International Journal of Molecular Sciences|February 13, 2025
Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome AnalysesPritsana Raungrut, Jirapon Jirapongsak, Suchanan Tanyapattrapong, et al.
Pageof 1